Laboratorios Farma | ROVI - 营业利润

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 3.07B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	营业利润	更改		日
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.01M		175K	2026-03
Almirall	EUR 30.23M		12.8M	2025-12
Avita Medical	AUD -10.41M		742K	2025-12
Dianthus Therapeutics	USD -69.54M		29.25M	2025-12
Ionis Pharmaceuticals	USD -118M		97M	2026-03
IQVIA Holdings	USD 565M		2.11B	2026-03
Laboratorios Farma	EUR 135.05M		49.84M	2023-12
Moderna	USD -1.39B		531M	2026-03
Organon & Co	USD 217M		171M	2025-12
Pharma Mar	EUR 622K		42.99M	2026-03
Revvity	USD 82.77M		63.06M	2026-03
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Viatris	USD -20.2M		137.3M	2026-03
Xeris Pharmaceuticals	USD 16.77M		10.04M	2025-12